Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Common Links
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

About FDA
  • Print
  • Share
  • E-mail
-

FDA-TRACK Archive

The list below provides information on FDA's performance measures and projects as aligned to FDA strategic priorities and program offices. This list enables you to view charts of performance data and progress on important projects and programs.

To view current FDA-TRACK performance measures and projects view the Active Index

Filter







Results

Number of results:71

ItemProgramOfficeFY CompletedStrategic PlanStrategic Goal/Area
1 Total number of cross-agency speaking engagements received by OER during the month OC ADMIN Office of External Relations 2012 N/A N/A
2 Total number of cross-agency speaking engagements accepted by OER during the month OC ADMIN Office of External Relations 2012 N/A N/A
3 Total number of FDA external presentations delivered by FDA Centers within the month OC ADMIN Office of External Relations 2012 N/A N/A
4 Total number of Consumer Updates (articles, videos, and photo slide shows) posted each month on FDA.gov OC ADMIN Office of External Relations 2012 N/A N/A
5 Total number of individual visitors to the Consumer Update webpage each month OC ADMIN Office of External Relations 2012 N/A N/A
6 Total number of subscribers receiving e-mail notices of Consumer Updates from FDA.gov each month OC ADMIN Office of External Relations 2012 N/A N/A
7 External Relations Webpage OC ADMIN Office of External Relations 2012 N/A N/A
8 Total number of visits to fda.gov website within the month OC ADMIN Web Communications 2012 N/A N/A
9 Total number of times FDA used Web 2.0/social media tools to distribute agency content within the month OC ADMIN Web Communications 2012 N/A N/A
10 Total number of times FDA content was shared via AddThis during the month OC ADMIN Web Communications 2012 N/A N/A
11 Total number of times FDA content shared via AddThis was accessed as a ClickBack during the month OC ADMIN Web Communications 2012 N/A N/A
12 Total number of responses to FDA content via social media received during the month OC ADMIN Web Communications 2012 N/A N/A
13 Total number of views of FDA YouTube channel during the month OC ADMIN Web Communications 2012 N/A N/A
14 Number of FDA website surveys completed during the month OC ADMIN Web Communications 2012 N/A N/A
15 Overall website score OC ADMIN Web Communications 2012 N/A N/A
16 FDA Website Improvements OC ADMIN Web Communications 2012 N/A N/A
17 Press Operations OC ADMIN Office of Public Affairs 2012 N/A N/A
18 Number of webinars, meetings, and training with patients or patient groups during the month OC ADMIN Office of Special Health Issues 2012 N/A N/A
19 Percentage of FDA advisory committee meetings during the month, that were identified as needing a Patient Representative, that had a Patient Representative OC ADMIN Office of Special Health Issues 2012 N/A N/A
20 Number of educational activities on the regulation of human medical products for health professionals OC ADMIN Office of Special Health Issues 2012 N/A N/A
21 Number of information products about the regulation of human medical products distributed to health professionals/health professional organizations during the month OC ADMIN Office of Special Health Issues 2012 N/A N/A
22 Cumulative total number of email subscribers at month end OC ADMIN Office of Special Health Issues 2012 N/A N/A
23 Patient Network Website Development OC ADMIN Office of Special Health Issues 2012 N/A N/A
24 Social Media Communications OC ADMIN Office of Public Affairs 2010 N/A N/A
25 Targeted MedWatch Safety Alert Pilot OC ADMIN Office of Special Health Issues 2010 N/A N/A
26 Number of telephone and in-person briefings delivered within the month to Members of Congress and staff on current or new FDA programs, policies, and initiatives OC ADMIN Office of Policy, Planning, Legislation and Analysis 2015 N/A N/A
27 Number of e-mail messages sent within the month to Congressional staff informing them of new significant agency regulatory/legal actions OC ADMIN Office of Policy, Planning, Legislation and Analysis 2015 N/A N/A
28 Office of Legislation's Standard Operating Procedures OC ADMIN Office of Policy, Planning, Legislation and Analysis 2012 N/A N/A
29 Total number of FR documents reviewed by the Regulations Policy & Management Staff (RPMS) and the Regulations Editorial Section (RES) in the month OC ADMIN Office of Policy, Planning, Legislation and Analysis 2013 N/A N/A
30 Total number of FR documents returned to FDA by the OFR due to FDA errors in the month OC ADMIN Office of Policy, Planning, Legislation and Analysis 2013 N/A N/A
31 Percentage of documents eligible for digital signatures which were published in the FR with digital signatures within the month OC ADMIN Office of Policy, Planning, Legislation and Analysis 2013 N/A N/A
32 Number of current GAO Studies in progress in the month OC ADMIN Office of Policy, Planning, Legislation and Analysis 2015 N/A N/A
33 Total number of offices who participated in a quarterly briefing in the month OC ADMIN Office of Policy, Planning, Legislation and Analysis 2012 N/A N/A
34 Number of feedback and inquiry emails received via the FDA-TRACK email address in the month OC ADMIN Office of Policy, Planning, Legislation and Analysis 2011 N/A N/A
35 Focus Group Testing of Messages about Prescription Drug Risks and Benefits OC ADMIN Office of Policy, Planning, Legislation and Analysis 2012 N/A N/A
36 GAO Recommendations Update for 2011 OC ADMIN Office of Policy, Planning, Legislation and Analysis 2011 N/A N/A
37 Establish a Project Management Pilot Program in OCC OC ADMIN Office of the Chief Counsel 2011 N/A N/A
38 FDA Records Management Compliance OC ADMIN N/A 2011 N/A N/A
39 Performance Management / FDA-TRACK Initiative OC ADMIN Office of Policy, Planning, Legislation and Analysis 2010 N/A N/A
40 Number of new fact sheets posted on fda.gov during the month OC ADMIN Office of External Affairs 2015 OEA Strategic Plan Enhance consumer content and engagement
41 FDA Website Search Improvements OC ADMIN Office of External Affairs 2013 OEA Strategic Plan Enhance consumer content and engagement
42 Average American Customer Satisfaction Index (ACSI) evaluation score from surveys completed on the mobile site during the month OC ADMIN Office of External Affairs 2018 OEA Strategic Plan Provide leadership throughout the Agency on communication strategies and practices
43 Number of commmunication materials cleared during the month which followed HHS clearance procedures OC ADMIN Office of External Affairs 2016 OEA Strategic Plan Provide leadership throughout the Agency on communication strategies and practices
44 Percentage increase of FDA Facebook page likes received during the month OC ADMIN Office of External Affairs 2018 OEA Strategic Plan Provide leadership throughout the Agency on communication strategies and practices
45 Social Media Guidance OC ADMIN Office of External Affairs 2015 OEA Strategic Plan Provide leadership throughout the Agency on communication strategies and practices
46 Establish a Mobile Website OC ADMIN Office of External Affairs 2013 OEA Strategic Plan Provide leadership throughout the Agency on communication strategies and practices
47 Content Archiving/Expiration Project OC ADMIN Office of External Affairs 2013 OEA Strategic Plan Provide leadership throughout the Agency on communication strategies and practices
48 Number of visits to the FDA Patient Network Website during the month OC ADMIN Office of External Affairs 2018 OEA Strategic Plan Enhance outreach to external stakeholders
49 Average bounce rate of visitors to the newsroom on fda.gov during the month OC ADMIN Office of External Affairs 2018 OEA Strategic Plan Enhance outreach to external stakeholders
50 Number of MedWatch e-list subscribers during the month OC ADMIN Office of External Affairs 2018 OEA Strategic Plan Enhance outreach to external stakeholders
51 Establishment of FDA Newsroom on fda.gov OC ADMIN Office of External Affairs 2016 OEA Strategic Plan Enhance outreach to external stakeholders
52 Cumulative number of newsletters published during the fiscal year OC ADMIN Office of External Affairs 2016 OEA Strategic Plan Improve internal communications with FDA employees
53 Total correspondence received by OES during the month which require FDA response OC ADMIN Office of the Executive Secretariat 2018 OES Strategic Plan Respond effectively and efficiently to external correspondence and related inquiries from industry and the general public on behalf of the Commissioner
54 Total number of written correspondence requiring FDA response which are overdue at the end of the month OC ADMIN Office of the Executive Secretariat 2015 OES Strategic Plan Respond effectively and efficiently to external correspondence and related inquiries from industry and the general public on behalf of the Commissioner
55 Internal Electronic Newsletter OC ADMIN Office of External Affairs 2014 OEA Strategic Plan Improve internal communications with FDA employees
56 Number of Departmental meetings in the month related to HHS Health Disparities Plan Implementation OC ADMIN Office of Minority Health and Health Equity 2013 N/A N/A
57 Number of HHS and FDA working groups impacting health literacy led or participated in during the month OC ADMIN Office of Minority Health and Health Equity 2013 N/A N/A
58 Minority Health and Health Disparities Research and Collaboration Program OC ADMIN Office of Minority Health and Health Equity 2016 OCS Strategic Priorities Support mission critical targeted research and raise the profile of regulatory science
59 Strengthening FDA Outreach and Communication Programs to Minority Health Care Providers and Patients OC ADMIN Office of Minority Health and Health Equity 2014 OCS Strategic Priorities Support mission critical targeted research and raise the profile of regulatory science
60 Health Resources and Services Administration (HRSA) Patient Safety and Clinical Pharmacy Services Collaborative OC ADMIN Office of Women Health 2011 N/A N/A
61 Video Novella OC ADMIN Office of Women Health 2012 N/A N/A
62 Number of OWH staff attending venues and partner activities where women’s information is provided in the month OC ADMIN Office of Women Health 2014 N/A N/A
63 Total number of electronic OWH distributions in English and other foreign languages in the quarter OC ADMIN Office of Women Health 2014 N/A N/A
64 Total number of physical OWH distributions in English and other foreign languages in the quarter OC ADMIN Office of Women Health 2014 N/A N/A
65 Total number of OWH partner distributions in the quarter OC ADMIN Office of Women Health 2014 N/A N/A
66 Cumulative number of subscribers to OWH email lists and social media outlets at the end of the month OC ADMIN Office of Women Health 2014 N/A N/A
67 Cumulative number of abstracts, posters, presentations or publications by OWH staff accepted in the month OC ADMIN Office of Women Health 2014 N/A N/A
68 Women's Health Research Roadmap OC ADMIN Office of Women Health 2016 OCS Strategic Priorities Support mission critical targeted research and raise the profile of regulatory science
69 Encouraging Women to Utilize FDA Safe Medication Use Resources OC ADMIN Office of Women Health 2016 OCS Strategic Priorities Support mission critical targeted research and raise the profile of regulatory science
70 Diverse Women in Clinical Trials Awareness Campaign OC ADMIN Office of Women Health 2016 OCS Strategic Priorities Support mission critical targeted research and raise the profile of regulatory science
71 The Science of Sex and Gender in Human Health Modules III and IV OC ADMIN Office of Women Health 2015 OCS Strategic Priorities Support an environment of scientific excellence, learning and integrity

Note: The data provided on this website is produced on an ongoing basis for performance management purposes and is subject to change due to updates of preliminary estimates, corrections, or other reasons. In addition, FDA may change the type or amount of data provided on this website at any time. Information in the Archive Index may include measures and/or key projects for which activities are ongoing but no longer tracked as part of FDA-TRACK.
-
-